Establishing A Heart Recovery Center

August 27, 2019

A Significant Step in Managing Cardiogenic Shock

Dr. Hiram Bezerra discusses the first heart recovery center in his region, which will advance efforts to manage cardiogenic shock. Dr. Bezerra is the director of advanced coronary intervention and mechanical circulatory support at University Hospital Harrington Heart & Vascular Institute in Cleveland, Ohio.

Dr. Bezerra explains that despite evolution in the fields of interventional cardiology and cardiothoracic surgery in recent years, “we haven’t really moved the needle on cardiogenic shock.” He hopes that will be changing in the Cleveland area, thanks to a recent 5 million dollar donation to establish the heart recovery center.

Impella® is available in all cath labs in his system, even level 2 labs that do not handle complex cases. “Early deployment of therapy is key,” states Dr. Bezerra. Recognizing that most patients present in remote hospitals, he explains the importance of offering Impella early at every hospital so that patients can benefit from support and then be transferred in a state where heart recovery is still possible.

Dr. Bezerra describes how the leadership of the Harrington Institute and University Hospital recognizes that shock is a leading cause of mortality and cost. He explains that there’s support at all levels for establishing a cohesive team of intensivists, CT surgeons, interventional cardiologists, and heart failure specialists to collect data and establish protocols throughout all hospitals in the system.

Interviewer Dr. Shon Chakrabarti, notes that Cleveland is ripe for this sort of initiative because of the system of care they are establishing, including principles shown to work in shock, such as implementation of early MCS before intervention.

Noting exponential growth in the field of heart failure in recent years, Dr. Bezerra discusses his hopes for creating an environment that will draw talent to the Heart Recovery Center. He explains the need to offer comprehensive care from acute shock to heart recovery and from advanced therapies to transplant, and how the interventional cardiology community plays a central role in his vision.

Related Content:

Subscribe or join the conversation by following us on Twitter: @ProtectedPCI

NPS-179
IMP-354


To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/